rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Yonatan Malca

Director

Company insider

Files Form 4 as: Director, Entera Bio.

Every Form 4 they filed

In numbers

Trades disclosed
15
Buys
1
Sells
0
Bought
$20K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
1 Jan 2022
Last trade
7 Aug 2026
Last filed
7 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ENTX Entera BioDirector · Biotechnology · last 7 Aug 20261 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
7 Aug 2026filed 7 Aug 2026ENTX Entera BioBiotechnologySEC FORM 4 Code A—22,815 at $0.00filing
7 Aug 2026filed 7 Aug 2026ENTX Entera BioBiotechnologySEC FORM 4 Code A—22,815 at $0.00filing
1 Jan 2026filed 2 Jan 2026ENTX Entera BioBiotechnologySEC FORM 4 Code A—30,157 at $0.00filing
1 Jan 2026filed 2 Jan 2026ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—33,505 at $0.00filing
1 Jan 2026filed 2 Jan 2026ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—33,505 at $0.00filing
1 Jan 2026filed 2 Jan 2026ENTX Entera BioBiotechnologySEC FORM 4 Code A—30,157 at $0.00filing
15 Jan 2025filed 17 Jan 2025ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—28,509 at $0.00filing
15 Jan 2025filed 17 Jan 2025ENTX Entera BioBiotechnologySEC FORM 4 Code A—8,216 at $0.00filing
2 Oct 2024filed 4 Oct 2024ENTX Entera BioBiotechnologySEC FORM 4 Code A—8,639 at $0.00filing
27 Aug 2024filed 29 Aug 2024ENTX Entera BioBiotechnologySEC FORM 4 Code A—23,172 at $0.00filing
1 Jan 2024filed 3 Jan 2024ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—108,333 at $0.00filing
2 Jan 2023filed 4 Jan 2023ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—89,041 at $0.00filing
13 Jan 2022filed 18 Jan 2022ENTX Entera BioBiotechnologySEC FORM 4 Bought$20K7,232 at $2.74filing
1 Jan 2022filed 14 Jan 2022ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—35,852 at $0.00filing
1 Jan 2022filed 14 Jan 2022ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—107,557 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Gregory BurshteinChief of R&D · Chief of R&D at Entera Bio, filing Form 4 there in the last year
Steven D. RubinDirector · Director at Entera Bio, filing Form 4 there in the last year
Geno J. GermanoDirector · Director at Entera Bio, filing Form 4 there in the last year
Dana Yaacov-GarbeliChief Financial Officer · Chief Financial Officer at Entera Bio, filing Form 4 there in the last year
Haya TaitelDirector · Director at Entera Bio, filing Form 4 there in the last year